首页> 美国卫生研究院文献>Genes and Environment >Acid-specific formaldehyde donor is a potential dual targeting cancer chemotherapeutic/chemo preventive drug for FANC/BRCA-mutant cancer
【2h】

Acid-specific formaldehyde donor is a potential dual targeting cancer chemotherapeutic/chemo preventive drug for FANC/BRCA-mutant cancer

机译:酸特异性甲醛供体是针对FANC / BRCA突变型癌症的潜在双重靶向癌症化疗/化学预防药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Hypothetical mechanisms by which HMTA causes dual targeting effects on DNA repair-deficient cells. 1st targeting: Preferential formaldehyde delivery to cancer cells. Under the acidic conditions of the extracellular environment of cancer cells, HMTA is preferentially hydrolyzed to 6 molecules of formaldehyde and 4 molecules of ammonium ions. Therefore, formaldehyde preferentially introduces DPCs in cancer cells. 2nd targeting: Selective cell death for cancer cells. Formaldehyde selectively kills FANC/BRCA- and HR-deficient cells probably due to a deficiency in DPC repair. In contrast, normal cells are resistant to HMTA because less formaldehyde is formed in a neutral environment and they are proficient in the repair of formaldehyde induced DNA damage
机译:HMTA对DNA修复缺陷细胞产生双重靶向作用的假设机制。第一个目标:将甲醛优先递送至癌细胞。在癌细胞胞外环境的酸性条件下,HMTA优先水解为6分子甲醛和4分子铵离子。因此,甲醛优先将DPC引入癌细胞。第二目标:癌细胞的选择性细胞死亡。甲醛选择性地杀死FANC / BRCA和HR缺乏的细胞,可能是由于DPC修复的缺乏。相比之下,正常细胞对HMTA具有抗性,因为在中性环境中形成的甲醛较少,并且它们能熟练修复甲醛诱导的DNA损伤

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号